136 related articles for article (PubMed ID: 159862)
1. Human myeloma cells and their strong stimulating capacity in 'one-way' mixed lymphocyte reaction: a comparative study with leukaemic B lymphoid cells.
Han T; Dadey B; Minowada J; Golde DW
Immunology; 1979 Sep; 38(1):63-8. PubMed ID: 159862
[TBL] [Abstract][Full Text] [Related]
2. Use of stimulating capacity of mixed lymphocyte reaction (MLR-S) as a possible marker for the cell-origin of null-cell acute lymphoblastic leukaemia.
Han T; Minowada J
Immunology; 1978 Aug; 35(2):333-9. PubMed ID: 155647
[TBL] [Abstract][Full Text] [Related]
3. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
Han T; Gomez GA; Minowada J
Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
[TBL] [Abstract][Full Text] [Related]
4. Stimulating capacity of fresh and cultured human leukaemic lymphoid and myeloid cells in 'one-way' mixed lymphocyte reaction.
Han T; Dadey B; Minowada J
Immunology; 1977 Oct; 33(4):543-51. PubMed ID: 144702
[TBL] [Abstract][Full Text] [Related]
5. Human thymus cells. Excellent responders but poor stimulators in 'One Way' mixed lymphocyte reaction.
Han T; Minowada J; Subramanian S; Sinks LF
Immunology; 1976 Mar; 30(3):361-6. PubMed ID: 130342
[TBL] [Abstract][Full Text] [Related]
6. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
7. Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.
Halper JP; Fu SM; Gottlieb AB; Winchester RJ; Kunkel HG
J Clin Invest; 1979 Nov; 64(5):1141-8. PubMed ID: 159311
[TBL] [Abstract][Full Text] [Related]
8. Variation in accessory cell requirements in human mixed lymphocyte response to leukaemic cell lines.
O'Keefe D; Ashman L
Immunology; 1982 Dec; 47(4):633-41. PubMed ID: 6216200
[TBL] [Abstract][Full Text] [Related]
9. [Stimulating capacity of cultured human lymphoid and myeloid cells in allogenic 'one-way' mixed lymphocyte tumor cell reaction (author's transl)].
Nagatani T; Minato K; Saito H; Shimoyama M
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):788-95. PubMed ID: 6453494
[No Abstract] [Full Text] [Related]
10. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell antigens in human multiple myeloma.
Mackenzie MR; Paglieroni TG
J Lab Clin Med; 1977 May; 89(5):1009-17. PubMed ID: 67161
[TBL] [Abstract][Full Text] [Related]
12. T and B lymphocytes. Exclusive role as responders and stimulators in human one-way mixed lymphocyte reaction.
Han T; Dadey B
Immunology; 1976 Oct; 31(4):643-8. PubMed ID: 135726
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the alloactivated E+Ia+ cell capable of stimulating in mixed lymphocyte culture.
Shen HH; Irigoyen O; Friedman SM; Chess L
J Immunol; 1982 Jan; 128(1):501-5. PubMed ID: 6459379
[TBL] [Abstract][Full Text] [Related]
14. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
Kim SK; Nguyen Pham TN; Nguyen Hoang TM; Kang HK; Jin CJ; Nam JH; Chung SY; Choi SJ; Yang DH; Kim YK; Chung IJ; Kim HJ; Lee JJ
Ann Hematol; 2009 Nov; 88(11):1113-23. PubMed ID: 19277657
[TBL] [Abstract][Full Text] [Related]
15. An antigenic study of human plasma cells in normal tissue and in myeloma: identification of a novel plasma cell associated antigen.
Nathan PD; Walker L; Hardie D; Richardson P; Khan M; Johnson GD; Ling NR
Clin Exp Immunol; 1986 Jul; 65(1):112-9. PubMed ID: 3024883
[TBL] [Abstract][Full Text] [Related]
16. Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines.
Pauly JL; Minowada J; Han T; Moore GE
J Natl Cancer Inst; 1975 Mar; 54(3):557-62. PubMed ID: 123598
[TBL] [Abstract][Full Text] [Related]
17. Surface receptors on human haematopoietic cell lines.
Huber C; Sundström C; Nilsson K; Wigzell H
Clin Exp Immunol; 1976 Sep; 25(3):367-76. PubMed ID: 963908
[TBL] [Abstract][Full Text] [Related]
18. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
19. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
